• to decreased the risk of severe cardiovascular (heart and blood vessel) complications in Older people with variety two diabetes and cardiovascular diseaseIn Oct 2024, Novo Nordisk released a analyze on scientific journal Character a few novel glucose-sensitive insulin NNC2215 which can lower the risk of hypoglycemia in animal models.[67]We only